LANNETT CO INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021	FY2020 12 months to Jun 30, 2020	FY2019 12 months to Jun 30, 2019	FY2018 12 months to Jun 30, 2018
OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization
Deferred income tax expense (benefit)
Share-based compensation
Asset impairment charges
Loss (gain) on sale/disposal of assets
Gain on investment securities
Gain on sale of intangible assets
Loss on extinguishment of debt
Accrual of payment-in-kind interest on Second Lien Credit Facility
Amortization of debt discount and other debt issuance costs
Provision for inventory write-downs
Accrual of contingent liability
Other noncash expenses

Changes in assets and liabilities which provided (used) cash:
Accounts receivable, net
Inventories
Income taxes receivable/payable
Other assets
Rebates payable
Royalties payable
Restructuring liability
Operating lease assets/liabilities
Accounts payable
Accrued expenses
Accrued payroll and payroll-related expenses
Other liabilities
Net cash (used in) provided by operating activities
INVESTING ACTIVITIES:
Purchases of property, plant and equipment
Proceeds from sale of property, plant and equipment
Proceeds from sale of outstanding loan to Variable Interest Entity ("VIE")
Advance to VIE
Purchases of intangible assets
Proceeds from sale of investment securities
Purchase of investment securities
Net cash provided by (used in) investing activities

FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt
Purchase of capped call
Repayments of long-term debt
Proceeds from issuance of stock
Payment of debt issuance costs
Purchase of treasury stock
Net cash used in financing activities
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
Effect on cash and cash equivalents of changes in foreign exchange rates
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS, END OF PERIOD
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes (refunded) paid
Credits issued pursuant to a Settlement Agreement
Andor Pharmaceuticals, LLC ("Andor") License Agreement acquisition
Purchases of property, plant and equipment included in accounts payable
Issuance of warrant in connection with Second Lien Credit Facility

Comments